Dr. Karra is one of the key founding members of Clonz.
His 19 years of industrial experience in the field of molecular biology specifically cloning and expression of recombinant therapeutics is a significant asset to the company.
His extensive research work at different institutions includes his four years of postdoctoral research experience at Univ. of Maryland Cancer Center, USA, & the Cancer Institute of New Jersey, USA. He had 9 publications in international journals and two patents as his academic assets. Industrial experience in reputed Biotech / Pharma companies in the development of Biosimilars, currently helping the Clonz to build a strong pipeline of products.
Contact Dr.Karra at: email@example.com
Clonz biotech was founded in 2010 by an experienced team of recognized leaders in biosimilar research and manufacturing.